Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 230

    1.

    Rosiglitazone: a thunderstorm from scarce and fragile data.

    Mulrow CD, Cornell J, Localio AR.

    Ann Intern Med. 2007 Oct 16;147(8):585-7. No abstract available. PMID: 17938398 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The record on rosiglitazone and the risk of myocardial infarction.

    Psaty BM, Furberg CD.

    N Engl J Med. 2007 Jul 5;357(1):67-9. Epub 2007 Jun 5. No abstract available. PMID: 17551162 [PubMed - indexed for MEDLINE]Related articles

    3.

    Rosiglitazone and cardiovascular risk.

    Mannucci E, Monami M, Marchionni N.

    N Engl J Med. 2007 Aug 30;357(9):938; author reply 939-40. No abstract available. PMID: 17806136 [PubMed - indexed for MEDLINE]Related articles

    4.

    Rosiglitazone and cardiovascular risk.

    Diamond GA, Kaul S.

    N Engl J Med. 2007 Aug 30;357(9):938-9; author reply 939-40. No abstract available. PMID: 17806135 [PubMed - indexed for MEDLINE]Related articles

    5.

    Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death.

    Diamond GA, Bax L, Kaul S.

    Ann Intern Med. 2007 Oct 16;147(8):578-81. Epub 2007 Aug 6.PMID: 17679700 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Faster publication isn't always better.

    Fuster V, Farkouh ME.

    Nat Clin Pract Cardiovasc Med. 2007 Jul;4(7):345. No abstract available. PMID: 17589426 [PubMed - indexed for MEDLINE]Related articles

    7.

    Rosiglitazone and cardiovascular risk.

    Psaty BM, Furberg CD.

    N Engl J Med. 2007 Jun 14;356(24):2522-4. Epub 2007 May 21. No abstract available. PMID: 17517854 [PubMed - indexed for MEDLINE]Related articles

    8.

    Rosiglitazone and cardiovascular risk.

    Bracken MB.

    N Engl J Med. 2007 Aug 30;357(9):937-8; author reply 939-40. No abstract available. PMID: 17761600 [PubMed - indexed for MEDLINE]Related articles

    9.

    Rosiglitazone and cardiovascular disease: a cardiologist's perspective.

    Marx N.

    Diab Vasc Dis Res. 2007 Jun;4(2):80-1. No abstract available. PMID: 17654439 [PubMed - indexed for MEDLINE]Related articles

    10.

    Rosiglitazone and cardiovascular risk.

    Kaul S, Diamond GA.

    Curr Atheroscler Rep. 2008 Oct;10(5):398-404. Review.PMID: 18706281 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rosiglitazone and cardiovascular disease: an epidemiologist's perspective.

    McGuire DK.

    Diab Vasc Dis Res. 2007 Jun;4(2):77-9. No abstract available. PMID: 17654438 [PubMed - indexed for MEDLINE]Related articles

    12.

    Outlook on diabetes drug less than rosy. Early work suggests that rosiglitazone (Avandia) may not be best for the heart.

    [No authors listed]

    Harv Heart Lett. 2007 Aug;17(12):1-2. No abstract available. PMID: 17717888 [PubMed - indexed for MEDLINE]Related articles

    13.

    The rosiglitazone meta-analysis.

    McCullough PA, Lepor NE.

    Rev Cardiovasc Med. 2007 Spring;8(2):123-6. Review. No abstract available. Erratum in: Rev Cardiovasc Med. 2007 Summer;8(3):174. PMID: 17603430 [PubMed - indexed for MEDLINE]Related articles

    14.

    Thiazolidinediones and clinical diabetes management: new challenges for the fall of 2007.

    Boyle P.

    South Med J. 2007 Nov;100(11):1063-4. No abstract available. PMID: 17984728 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rosiglitazone--continued uncertainty about safety.

    Drazen JM, Morrissey S, Curfman GD.

    N Engl J Med. 2007 Jul 5;357(1):63-4. Epub 2007 Jun 5. No abstract available. PMID: 17551160 [PubMed - indexed for MEDLINE]Related articles

    16.

    Rosiglitazone and cardiovascular disease: a diabetologist's perspective.

    Grant PJ.

    Diab Vasc Dis Res. 2007 Jun;4(2):75-6. No abstract available. PMID: 17654437 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

    Nissen SE, Wolski K.

    N Engl J Med. 2007 Jun 14;356(24):2457-71. Epub 2007 May 21. Erratum in: N Engl J Med. 2007 Jul 5;357(1):100.. PMID: 17517853 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Group.

    N Engl J Med. 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.PMID: 17551159 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    The safety of rosiglitazone in the treatment of type 2 diabetes.

    Singh S, Loke YK.

    Expert Opin Drug Saf. 2008 Sep;7(5):579-85. Review.PMID: 18759710 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pioglitazone and the risk of myocardial infarction and other major adverse cardiac events: a meta-analysis of randomized, controlled trials.

    Nagajothi N, Adigopula S, Balamuthusamy S, Velazquez-Cecena JL, Raghunathan K, Khraisat A, Singh S, Molnar J, Khosla S, Benatar D.

    Am J Ther. 2008 Nov-Dec;15(6):506-11.PMID: 19127132 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data